Pharmacovigilance & Patient Safety:
Post marketing surveillance is monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.
From versatile technologies and targeted data collection and analysis to in-depth reporting and regulatory compliance, we provide a comprehensive range of pharmacovigilance services throughout the product life cycle to detect, assess, understand, and prevent adverse effects or any other drug-related issues, compliant with EMA, FDA and ICH, ultimately making patients’ lives better.
We ensure that this is a comprehensive yet cost-effective process, enabling full compliance with legal requirements. We have a team of fully qualified medical professionals acting as QPPV’s with with European, US or Global coverage.
Comprehensive, Compliant and Customised solutions
At the heart of our commitment to patient safety lies a robust pharmacovigilance ecosystem – designed to support every phase of the product lifecycle. Whether you need an end-to-end solution or a region-specific service, our flexible model is built around your product portfolio and regulatory landscape.
Our services are delivered through strategically located offices in the UK and the Netherlands, supported by a global team of pharmacovigilance experts, offering a truly global reach with local expertise.
Build your safety strategies with us
Whether launching a new molecule or maintaining post-marketing surveillance, we’re here to support you with scalable, compliant, and expert-led pharmacovigilance solutions.
Ready to elevate your safety systems?
Contact our PV Team
